MassBio Annual Meeting

Thursday, March 14 – Friday, March 15 2013

Location: Royal Sonesta Hotel, 40 Edwin Land Blvd, Cambridge, MA

 

AM

JUST ANNOUNCED: John Crowley, Chairman & CEO of Amicus Therapeutics, Inc. and FDA Commissioner Margaret Hamburg will deliver Keynote Addresses

The agenda is final!

 

Science Track Sessions:

Personalized Medicine & Companion Diagnostics

Oncology: Where are the Future Opportunities?

Neurodegenerative Diseases

Antibody Drug Conjugates

RNA Therapeutics

Business Track Sessions:

What Does Pharma Really Want? External R&D

Healthcare Reimbursement Strategies

The Future of Biosimilars

Rare Disease Therapies: Is the Current Payer Model Sustainable?

Antibiotics, Anti-infective, & Anti-Virals from a Business Perspective

Conference-Wide Discussions:

Research Resource Sharing: Challenges & Opportunities

Overcoming Barriers in Translational Drug Development

And don’t miss the:

  • Awards Luncheon featuring recipients of the Henri Termeer Innovative Leadership Award and the Joshua Boger Innovative School of the Year Award
  • Leading Impact Award Presentation
  • Annual State of MassBio Address & Board Elections
  • Poster competition
  • And much more!

 

 

2012 MassBio Annual Meeting Attendees:

By Organization Type: 45% Pharma/Biotechnology; 28% Academic Institutions; 26% Service Providers

By Industry: 69% Drug Development; 13% Research Products and Instrumentation; 12% Contract Research and Manufacturing; 13% Other (Human Diagnostic Development, Medical Device, etc.)

By Title: 22% Top Management (CEO, CSO, President);  40% Sr. Management (Director, VP); 38% Middle Management/Other

 

Why should your organization be there?

Biotech companies: Engage in thoughtful panel discussions, networking activities and presentation opportunities with potential collaborators.
Pharma companies: Forge relationships with academia, disease foundations and biotech companies.
Disease foundations: Form partnerships with biotech and Pharma companies around programs addressing your patient constituencies; meet with leading academicians in your therapeutic space.
Venture capitalists: See groundbreaking technologies during our poster presentation.
Corporate strategists: Meet leaders of companies useful to your strategies for pipeline growth.
Academic Medical Centers: You are the engines of innovation! Come meet your future industrial collaborators. Meet biotech and pharma companies. They want to meet you!

 

Sponsorship opportunities are available. Please contact Elizabeth.Steele@massbio.org for more information.

Share MassBio

 

MassBio

EvaluatePharma